Lv1
40 积分 2023-07-26 加入
Final results of nilotinib versus nilotinib combined with pegylated interferon alfa-2a as first-line therapy in chronic phase chronic myeloid leukaemia in France (PETALs): an open-label, multicentre, randomised phase 3 trial
1个月前
已完结
Cost estimation for spinal muscular atrophy diagnosis using multiplex ligation-dependent probe amplification and droplet digital polymerase chain reaction
1个月前
已关闭
[Impact of confined placental mosaicism on non-invasive prenatal testing and pregnancy outcomes]
3个月前
已完结
A female with typical fragile-X phenotype caused by maternal isodisomy of the entire X chromosome
4个月前
已完结
Newborn screening programs for spinal muscular atrophy worldwide in 2023
4个月前
已完结
Toward Comprehensive Detection of the SMN1/2 Genotypes
5个月前
已关闭
Overview of therapeutic drug monitoring of immunosuppressive drugs: Analytical and clinical practices
5个月前
已完结
Cost-utility analysis of newborn screening for spinal muscular atrophy in Japan
8个月前
已完结
Newborn screening for spinal muscular atrophy with disease-modifying therapies: a cost-effectiveness analysis
8个月前
已完结
Linezolid pharmacokinetics: a systematic review for the best clinical practice
8个月前
已完结
皖公网安备34019202002308
